anandvkulkarni.bsky.social
Hepatologist at AIG Hospitals, Hyderabad, India. Interests in ALD, ACLF & HCC
17 posts
453 followers
322 following
Regular Contributor
Conversation Starter
comment in response to
post
Thank you 🙏🏻
comment in response to
post
Yes . No doubt 😞
comment in response to
post
Thank you Hanna. In our settings most patients don’t agree for LT at all & we see at least 4 new AH patients per day and hardly one may fit for steroids therapy up front. We usually stabilize and then start steroids. Under supervision they do pretty well.
comment in response to
post
Thank you Rohit
comment in response to
post
@rohitmehtani.bsky.social @hughthomas00.bsky.social @robbrierley.bsky.social @spaulliver.bsky.social @andrewmmoon.bsky.social @heykatray.bsky.social @anaostojic.bsky.social @vivekgtank.bsky.social @wongyujun.bsky.social @jonathanstinemd.bsky.social @kbibbinsdomingo.bsky.social
comment in response to
post
Tips cannot prevent cirrhosis progression. Patients are okay without bleed for 3-4 years- then continue to develop complications. Having said that yes,I strongly recommend TIPS for bleeders but not for refractory ascites.Very poor outcomes! The QoL post TIPS for ascites is significantly affected.
comment in response to
post
Absolutely sir. Patient selection is the key!
comment in response to
post
Hey Vinay, thank you. Nice meeting you.
Best
comment in response to
post
Dose tapering reduced incidence of infection and use of antibiotics. No difference noted in survival #TLM24 #LiverSky
comment in response to
post
No difference in mortality though.